Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2021 Q2 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2021 Q2 - Results - Earnings Call Presentation
Teva Pharmaceutical Industries Limited (TEVA) Q2 2021 Results Conference Call July 28, 2021 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President, Head of Investor Relations Kåre Schultz - Chief Executive Officer Eli Kalif - Chief Financial Officer Brendan O'Grady - Head ...
The denied request is likely the last chance to stop the Tennessee damages trial set to begin on July 26. The company already has a default judgment against it. The company could face a $2.4 billion judgment leveled against it. Appeal denial is one more piece pointing to likel...
A Tennessee state court issued a "default judgement" in April against the company in the lawsuit by county prosecutors over the company's generic for oxycontin, Opana. Earlier this month, a Tennessee appellate court declined to review that default judgement. The damages trial...
David Abrams’ 13F portfolio value increased ~25% this quarter from $3.55B to $4.44B. The number of positions decreased from 17 to 16. Abrams Capital Management added Change Healthcare while dropping TransMedics Group during the quarter. The top three positions are Lithia Mo...
HIX is heavily invested in various fixed-income securities, which could come under pressure in a period of higher inflation or rising interest rates. HIX has been able to weather the challenges of the COVID-19 pandemic exceptionally well over the last year. The fund offers a month...
AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...
Teva Pharmaceutical Industries Limited (TEVA) Q1 2021 Earnings Conference Call April 28, 2021 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President, Head of Investor Relations Kåre Schultz - Chief Executive Officer Eli Kalif - Chief Financial Officer Brendan O'Grady - Hea...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2021 Q1 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2021 Q1 - Results - Earnings Call Presentation
Bristol-Myers Squibb is currently enjoying a diversified asset portfolio whose sales are expected to keep growing going forward. The stock's valuation is hard to justify even when accounting for patent expirations potentially hurting revenues post-2025. The company is a free cash ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: